Standout Papers

Safety, Efficacy, and Feasibility of Intranasal Insulin for the Treatment of Mild Cognitive Impairment and Al... 2020 2026 2022 2024247
  1. Safety, Efficacy, and Feasibility of Intranasal Insulin for the Treatment of Mild Cognitive Impairment and Alzheimer Disease Dementia (2020)
    Suzanne Craft, Rema Raman et al. JAMA Neurology

Immediate Impact

1 from Science/Nature 61 standout
Sub-graph 1 of 22

Citing Papers

Mechanisms of autophagy–lysosome dysfunction in neurodegenerative diseases
2024 Standout
Recent advances in Alzheimer’s disease: mechanisms, clinical trials and new drug development strategies
2024 Standout
10 intermediate papers

Works of Kelly Harless being referenced

Safety, Efficacy, and Feasibility of Intranasal Insulin for the Treatment of Mild Cognitive Impairment and Alzheimer Disease Dementia
2020 Standout

Author Peers

Author Last Decade Papers Cites
Kelly Harless 62 65 12 125 5 301
Deborah Dahl 64 22 2 158 8 309
Gary Fierer 22 42 6 36 8 368
Harald G. Scholand-Engler 76 18 1 108 8 322
Nancy Maurya 40 28 3 97 9 344
Jean Viggers 16 51 8 44 8 336
Julie Vignisse 36 10 45 80 9 360
Lulu Cui 50 25 10 56 6 322
Mitsuhiko Hokari 43 14 11 91 7 331
Ashley Selman 54 23 2 166 7 299
Tímea Varga 58 88 4 56 4 359

All Works

Loading papers...

Rankless by CCL
2026